Berger, M. G., Lebecque, B., Tassin, T., Dannus, L., Berger, J., Soucal, M., . . . Bourgne, C. (2021). Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells. Nature Portfolio.
Cita Chicago Style (17a ed.)Berger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
Cita MLA (8a ed.)Berger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.